Login
$HYPR
$0.62 +$0.01 (2.02%) After hours

$HYPR SEC Filings

Filed On Filing
09 Nov 2026 S-3
09 Nov 2026 10-Q
09 Nov 2026 8-K: Results of Operations and Financial Condition

GUILFORD, Conn.--(BUSINESS WIRE)--November 9, 2026--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the...

08 Oct 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Exhibit 99.2 AI-POWERED, PORTABLE BRAIN MRI ® The Swoop Portable MR Imaging System is Driving the Future of Brain Health Corporate Investor Deck – October 2026 The Hyperfine logo, Swoop, and Portable MR Imaging are registered trademarks ...

18 Sep 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

On September 17, 2026, Hyperfine, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the clos...

25 Aug 2026 Form 4: Teisseyre Thomas, Chief Operating Officer

Sold 7,345 shares ($6.27K)

25 Aug 2026 Form 4: Hale Brett, CFO and CAO

Sold 7,345 shares ($6.27K)

06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition

GUILFORD, Connecticut, August 6, 2026 (GLOBE NEWSWIRE) – Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR)...

28 Jul 2026 SCHEDULE 13G
04 Jun 2026 Form 4: Wolterman Dan, Director

Granted 52,600 Stock Options (right to buy)

27 May 2026 Form 4: Hale Brett, CFO and CAO

Sold 6,047 shares ($9.98K)

27 May 2026 Form 4: Teisseyre Thomas, Chief Operating Officer

Sold 6,047 shares ($9.98K)

22 May 2026 Form 4: Fattori Ruth A, Director

Granted 157,700 Stock Options (right to buy)

22 May 2026 Form 4: Wolterman Dan, Director

Granted 157,700 Stock Options (right to buy)

22 May 2026 Form 4: Dahldorf John T, Director

Granted 157,700 Stock Options (right to buy)

22 May 2026 Form 4: Rothberg Jonathan M, Director

Granted 157,700 Stock Options (right to buy)

21 May 2026 EFFECT
21 May 2026 8-K: Submission of Matters to a Vote of Security Holders

On May 21, 2026, Hyperfine, Inc. (the “Company”) held its 2026 annual meeting of stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on two proposals, each of which is described in more detail in ...

19 May 2026 CORRESP

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support